The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cyclosporine: A Review
Open accessAbstract
The discovery and use of cyclosporine since its inception into clinical use in the late 1970s has played a major role in the advancement of transplant medicine. While it has improved rates of acute rejection and early graft survival, data on long-term survival of renal allografts is less convincing. The finding of acute reversible nephrotoxicity and nephrotoxicity in nonrenal transplants has since led to the widely accepted view that there is a chronic more irreversible component to this agent as well. Since that time, there has been intense interest in finding protocols which seek to minimize and even avoid the use of calcineurin inhibitors altogether. We seek to review cyclosporine in terms of its mechanism of action, pathophysiologic, and histologic features associated with acute and chronic nephrotoxicity and recent studies looking to avoid its toxic side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Renal Failure after Transplantation of a Nonrenal Organ
Ojo, A. O., Held, P. J., Port, F. K., Wolfe, R. A., Leichtman, A. B., Young, E. W., Arndorfer, J., Christensen, L., & Merion, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021744 · Cited by 2,220
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
Hariharan, S., Johnson, C. P., Bresnahan, B. A., Taranto, S. E., McIntosh, M. J., & Stablein, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003023420901 · Cited by 1,835
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
Ekberg, H., Tedesco-Silva, H., Demirbas, A., Vítko, Š., Nashan, B., Gürkan, A., Margreiter, R., Hugo, C., Grinyó, J. M., Frei, U., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067411 · Cited by 1,810
Calcineurin Inhibitor Nephrotoxicity
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04800908 · Cited by 1,489
Oates, J. A., Wood, A. J. J., & Kahan, B. D. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912213212507 · Cited by 1,359
Cyclosporine-Associated Chronic Nephropathy
Myers, B. D., Ross, J., Newton, L., Luetscher, J., & Perlroth, M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409133111103 · Cited by 1,144
Calne, R. Y., Rolles, K., Thiru, S., Mcmaster, P., Craddock, G. N., Aziz, S., White, D. J. G., Evans, D. B., Dunn, D. C., Henderson, R. G., et al. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92440-1 · Cited by 1,083
CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS
Calne, R. Y., Thiru, S., Mcmaster, P., Craddock, G. N., White, D. J. G., Evans, D. B., Dunn, D. C., Pentlow, B. D., & Rolles, K. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91970-0 · Cited by 1,002
Vincenti, F., Charpentier, B., Vanrenterghem, Y., Rostaing, L., Bresnahan, B., Darji, P., Massari, P., Mondragon‐Ramirez, G. A., Agarwal, M., Di Russo, G., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.03005.x · Cited by 957
ANTI-ESCHERICHIA COLI ALPHA-HAEMOLYSIN IN CONTROL AND PATIENT SERA
Emody, L., Batai, I., Kerényi, M., Székely, J., & Polyak, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90183-0 · Cited by 800
GYNAECOLOGISTS' ATTITUDES TO ABORTION
Savage, W., & Francome, C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91922-3 · Cited by 604
The long-term course of cyclosporine-associated chronic nephropathy
Myers, B. D., Sibley, R., Newton, L., Tomlanovich, S. J., Boshkos, C., Stinson, E., Luetscher, J. A., Whitney, D. J., Krasny, D., Coplon, N. S., et al. (1988) · Kidney International · doi:10.1038/ki.1988.38 · Cited by 506
Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology
Nankivell, B. J., Borrows, R. J., Fung, C. L.-S., O'Connell, P. J., Chapman, J. R., & Allen, R. D. M. (2004) · Transplantation · doi:10.1097/01.tp.0000128636.70499.6e · Cited by 498
Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure
Gaston, R. S., Cecka, J. M., Kasiske, B. L., Fieberg, A. M., Leduc, R., Cosio, F. C., Gourishankar, S., Grande, J., Halloran, P., Hunsicker, L., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e065de · Cited by 493
Renin-Angiotensin-Aldosterone System and Progression of Renal Disease
Rüster, C., & Wolf, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040356 · Cited by 463
Effect of cyclosporine administration on renal hemodynamics in conscious rats
Murray, B. M., Paller, M. S., & Ferris, T. F. (1985) · Kidney International · doi:10.1038/ki.1985.196 · Cited by 419
Larson, T. S., Dean, P. G., Stegall, M. D., Griffin, M. D., Textor, S. C., Schwab, T. R., Gloor, J. M., Cosio, F. G., Lund, W. J., Kremers, W. K., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01177.x · Cited by 299
Wolf, G. (2006) · Kidney International · doi:10.1038/sj.ki.5001846 · Cited by 292
Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity.
Borel, J. F. (1976) · PubMed · Cited by 264
Long-Term Efficacy and Safety of Cyclosporine in Renal-Transplant Recipients
Burke, J. F., Pirsch, J. D., Ramos, E. L., Salomon, D. R., Stablein, D. M., Van Buren, D. H., & West, J. C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310604 · Cited by 264
Mannon, R. B., Matas, A. J., Grande, J., Leduc, R., Connett, J., Kasiske, B., Cecka, J. M., Gaston, R. S., Cosio, F., Gourishankar, S., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03240.x · Cited by 230
Kuypers, D. R. J., de Jonge, H., Naesens, M., Lerut, E., Verbeke, K., & Vanrenterghem, Y. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100216 · Cited by 209
Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity
Barros, E. J. G., Boim, M. A., Ajzen, H., Ramos, O. L., & Schor, N. (1987) · Kidney International · doi:10.1038/ki.1987.166 · Cited by 208
REVERSIBILITY OF AIRFLOW OBSTRUCTION
Postma, D. S., & SLUITER, H. J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91377-3 · Cited by 145
Cyclosporine produces endothelial dysfunction by increased production of superoxide.
Diederich, D. A., Skopec, J., Diederich, A., & Dai, F. X. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.957 · Cited by 116
Quteineh, L., Verstuyft, C., Furlan, V., Dürrbach, A., Letierce, A., Ferlicot, S., Taburet, A., Charpentier, B., & Becquemont, L. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00327.x · Cited by 114
REVERSIBILITY OF CYCLOSPORIN NEPHROTOXICITY AFTER THREE MONTHS' TREATMENT
Chapman, J. R., Harding, N. G. L., Griffiths, D., & Morris, P. J. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91902-6 · Cited by 106
An Integrated View of Molecular Changes, Histopathology and Outcomes in Kidney Transplants
Halloran, P. F., de Freitas, D. G., Einecke, G., Famulski, K. S., Hidalgo, L. G., Mengel, M., REEVE, J. P., Sellarés, J., & Sis, B. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03268.x · Cited by 94
Hortelano, S., Castilla, M., Torres, A. M., Tejedor, A., & Boscá, L. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11122315 · Cited by 92
CYCLOSPORINE NEPHROTOXICITY IN LUNG TRANSPLANT RECIPIENTS
Zaltzman, J. S., Pei, Y., Maurer, J., Patterson, A. M., & Cattran, D. C. (1992) · Transplantation · doi:10.1097/00007890-199211000-00021 · Cited by 84
Williams, D., & Haragsim, L. (2006) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.11.001 · Cited by 81
Self-citationMorris, P. J., Allen, R. D. M., Thompson, J. F., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90233-9 · Cited by 80
Cyclosporine enhances the expression of TGF-β in the juxtaglomerular cells of the rat kidney
Shehata, M., Cope, G. H., Johnson, T. S., Raftery, A. T., & Nahas, A. M. E. (1995) · Kidney International · doi:10.1038/ki.1995.438 · Cited by 79
Cyclosporine A Suppresses Cyclooxygenase-2 Expression in the Rat Kidney
Höcherl, K., Dreher, F., Vitzthum, H., Diaeresis]hler, J. K., & Kurtz, A. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000031702.86799.b9 · Cited by 79
Long-Term Renal Effects of Low-Dose Cyclosporine in Uveitis-Treated Patients
Bagnis, C. I., du Montcel, S. T., Beaufils, H. A. A. G. A., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034945.61533.26 · Cited by 71
The Pharmacogenetics of Calcineurin Inhibitor–Related Nephrotoxicity
Hesselink, D. A., Bouamar, R., & van Gelder, T. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181e44244 · Cited by 70
Chronic Progressive Calcineurin Nephrotoxicity: An Overstated Concept
Matas, A. J. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03505.x · Cited by 65
Pharmacogenetics in solid organ transplantation: current status and future directions
de Jonge, H., & Kuypers, D. R. J. (2007) · Transplantation Reviews · doi:10.1016/j.trre.2007.09.002 · Cited by 64
Cyclosporine-Induced Renal Injury Induces Toll-like Receptor and Maturation of Dendritic cells
Lim, S. W., Li, C., Ahn, K. O., Kim, J., Moon, I. S., Ahn, C., Lee, J. R., & Yang, C. W. (2005) · Transplantation · doi:10.1097/01.tp.0000173594.69089.a0 · Cited by 59
Étienne, I., Toupance, O., Bénichou, J., Thierry, A., Najjar, A. A., de Ligny, B. H., Meur, Y. L., Westeel, P. F., Marquet, P., François, A., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq135 · Cited by 30
Steroid and Calcineurin Inhibitor—Sparing Protocols in Kidney Transplantation
Helal, I., & Chan, L. K. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.01.054 · Cited by 27
Dharancy, S., lannelli, A., Lesne-Hulin, A., Declerck, N., Schneck, A., Mathurin, P., Boleslawski, E., Gugenheim, J., & Pruvot, F. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02529.x · Cited by 27
Cited by
A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics
Mutua, V., & Gershwin, L. J. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08804-7 · Cited by 639
A critical review on exploiting the pharmaceutical potential of plant endophytic fungi
Gupta, S., Chaturvedi, P., Kulkarni, M. G., & Van Staden, J. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107462 · Cited by 346
Mitochondrial Quality Control as a Therapeutic Target
Suliman, H. B., & Piantadosi, C. A. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011502 · Cited by 264
On phagocytes and macular degeneration
Guillonneau, X., Eandi, C. M., Paques, M., Sahel, J.-A., Sapieha, P., & Sennlaub, F. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.06.002 · Cited by 185
Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation
Calippe, B., Augustin, S., Beguier, F., Charles-Messance, H., Poupel, L., Conart, J.-B., Hu, S. J., Lavalette, S., Fauvet, A., Rayes, J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.006 · Cited by 168
Metadata
- Authors
- Tedesco, D., & Haragsim, L.
- Venue
- Journal of Transplantation
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-7
- ISSN
- 2090-0007 (ISSN-L)
- 2090-0015
- OpenAlex
- W2080616886
- Cited by
- 302
- References
- 42
- FWCI
- 13.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.